S. 483, titled the "Responsibility in Drug Advertising Act of 2025," seeks to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising. The bill prohibits advertising a newly approved drug directly to consumers, including on social media...
Simple Explanation
S. 483 is a new rule that says companies can't show ads for new medicines on TV or the internet for the first three years they are available, but there might be a way to advertise sooner if it's important for people's health.